Business
Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook
INDIANAPOLIS, January 28, 2026--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results.
About this update from Elevance Health, Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion","length":69,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33","length":61,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29","length":63,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Projected FY 2026 GAAP diluted EPS1 to be at least $22.30","length":57,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Projected FY 2026 adjusted diluted EPS2 to be at least $25.50","length":61,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Returned $4.1 billion of capital to shareholders in 2025","length":56,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reaffirming long-term earnings algorithm; recalibrating segment margin targets","length":78,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":445,"olType":false},{"type":"text","content":"INDIANAPOLIS, January 28, 2026--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results.","length":134,"tagName":"p"},{"type":"text","content":""Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As we enter 2026, our focus is on advancing affordability and making healthcare easier to access and navigate for the members we serve. Through pricing discipline and targeted investments, we are strengthening the earnings power of our diversified platform and remain confident in our ability to return to at least 12% adjusted EPS growth in 2027."","length":493,"tagName":"p"},{"type":"text","content":"Gail K. BoudreauxPresident and Chief Executive Officer","length":55,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","val":[{"type":"text","content":"1.","length":2,"tagName":"p"}]},{"colspan":"1","rowspan":"1","val":[]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;","val":[{"type":"text","content":"Earnings per diluted share ("EPS").","length":45,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","val":[{"type":"text","content":"2.","length":...